AnaptysBio Inc (ANAB)
26.40
+0.06
(+0.23%)
USD |
NASDAQ |
May 03, 11:57
AnaptysBio Max Drawdown (5Y): 92.08% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 92.08% |
March 31, 2024 | 92.08% |
February 29, 2024 | 92.08% |
January 31, 2024 | 92.08% |
December 31, 2023 | 92.08% |
November 30, 2023 | 92.08% |
October 31, 2023 | 92.08% |
September 30, 2023 | 92.08% |
August 31, 2023 | 92.08% |
July 31, 2023 | 92.08% |
June 30, 2023 | 92.08% |
May 31, 2023 | 92.08% |
April 30, 2023 | 92.08% |
March 31, 2023 | 92.08% |
February 28, 2023 | 92.08% |
January 31, 2023 | 92.08% |
December 31, 2022 | 92.08% |
November 30, 2022 | 92.08% |
October 31, 2022 | 92.08% |
September 30, 2022 | 92.08% |
August 31, 2022 | 92.08% |
July 31, 2022 | 92.08% |
June 30, 2022 | 92.08% |
May 31, 2022 | 92.08% |
April 30, 2022 | 92.08% |
Date | Value |
---|---|
March 31, 2022 | 92.08% |
February 28, 2022 | 92.08% |
January 31, 2022 | 92.08% |
December 31, 2021 | 92.08% |
November 30, 2021 | 92.08% |
October 31, 2021 | 92.08% |
September 30, 2021 | 92.08% |
August 31, 2021 | 92.08% |
July 31, 2021 | 92.08% |
June 30, 2021 | 92.08% |
May 31, 2021 | 92.08% |
April 30, 2021 | 92.08% |
March 31, 2021 | 92.08% |
February 28, 2021 | 92.08% |
January 31, 2021 | 92.08% |
December 31, 2020 | 92.08% |
November 30, 2020 | 92.08% |
October 31, 2020 | 92.08% |
September 30, 2020 | 92.08% |
August 31, 2020 | 92.08% |
July 31, 2020 | 92.08% |
June 30, 2020 | 92.08% |
May 31, 2020 | 92.08% |
April 30, 2020 | 92.08% |
March 31, 2020 | 92.08% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
56.90%
Minimum
May 2019
92.08%
Maximum
Nov 2019
89.41%
Average
92.08%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
XOMA Corp | 86.82% |
Fate Therapeutics Inc | 98.59% |
Ocular Therapeutix Inc | 94.06% |
Apellis Pharmaceuticals Inc | 74.65% |
Stoke Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -18.19 |
Beta (5Y) | -0.3161 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.61% |
Historical Sharpe Ratio (5Y) | -0.3118 |
Historical Sortino (5Y) | -0.5141 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.00% |